FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/04/108383 [Registered on: 15/04/2026] Trial Registered Prospectively
Last Modified On: 15/04/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Dentistry 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Comparing the Effectiveness of Bakul Bark Extract (Used Locally vs. Orally) for Treating Severe Gum Disease 
Scientific Title of Study   Comparative Evaluation of the Efficacy of Systemically and Locally Administered Bakul (mimusops elengi) bark Extracts as an Adjunct to Scaling and Root Planing in Generalized Moderate to Severe Chronic Periodontitis:A Randomized Double-Blind Placebo-Controlled Clinical Trial 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Thenmozhi B R 
Designation  MDS PURSUING 
Affiliation  GOVERNMENT DENTAL COLLEGE AND HOSPITAL GHATI CAMPUS AURANGABAD 
Address  GOVERNMENT DENTAL COLLEGE AND HOSPITAL GHATI CAMPUS AURANGABAD
GOVERNMENT DENTAL COLLEGE AND HOSPITAL GHATI CAMPUS AURANGABAD
Aurangabad
MAHARASHTRA
431001
India 
Phone  7339187345  
Fax    
Email  thenmozhi86dr@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR C D DHALKARI 
Designation  professor and HOD 
Affiliation  GOVERNMENT DENTAL COLLEGE AND HOSPITAL GHATI CAMPUS AURANGABAD 
Address  GOVERNMENT DENTAL COLLEGE AND HOSPITAL GHATI CAMPUS AURANGABAD
GOVERNMENT DENTAL COLLEGE AND HOSPITAL GHATI CAMPUS AURANGABAD
Aurangabad
MAHARASHTRA
431001
India 
Phone    
Fax    
Email  cddhalkari@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR THENMOZHI B R 
Designation  MDS PURSUING 
Affiliation  GOVERNMENT DENTAL COLLEGE AND HOSPITAL GHATI CAMPUS AURANGABAD 
Address  GOVERNMENT DENTAL COLLEGE AND HOSPITAL GHATI CAMPUS AURANGABAD
GOVERNMENT DENTAL COLLEGE AND HOSPITAL GHATI CAMPUS AURANGABAD
Aurangabad
MAHARASHTRA
431001
India 
Phone  7339187345  
Fax    
Email  thenmozhi86dr@gmail.com  
 
Source of Monetary or Material Support  
Nil 
 
Primary Sponsor  
Name  DR THENMOZHI B R 
Address  GOVERNMENT DENTAL COLLEGE AND HOSPITAL GHATI CAMPUS,Naralibagh,chh.sambhajinagar-431001 AURANGABAD 
Type of Sponsor  Other [SELF FUNDED] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Thenmozhi B R   Government dental college and hospital  dept no;154,1st floor,Ghati campus, chh.sambhajinagar
Aurangabad
MAHARASHTRA 
7339187345

thenmozhi86dr@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
iec  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Chronic periodontitis  
Patients  (1) ICD-10 Condition: K053||Chronic periodontitis,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: tinospora cordifolia, Reference: na, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 1(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: placebo
2Intervention ArmDrugClassical(1) Medicine Name: bakul(mimusops elengi), Reference: bhavprakash nighantu, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 1(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: -
3Comparator ArmDrugClassical(1) Medicine Name: bakul mouthwash, Reference: bhavprakash nigantu, Route: Topical, Dosage Form: Arka, Dose: 10(ml), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: -
4Comparator ArmDrugClassical(1) Medicine Name: bakul , Reference: bhavprakash nigantu, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 1(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: -mouthwash and capsules
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1. Patients aged 30-65 years with generalized moderate to severe chronic periodontitis.

2. Patients with at least 20 natural teeth.

3. Patients willing to give written informed consent.

 
 
ExclusionCriteria 
Details  1. Systemically compromised patients, including those with uncontrolled systemic conditions.
2. Patients receiving ongoing antibiotic or antimicrobial
therapy.
3. Smokers or users of smokeless tobacco.
4. Individuals who have received periodontal therapy in the last 6 months.
5. Pregnant or lactating women.
6. Allergy to the material.
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
• Modified Gingival Index (MGI) by Lobene et al., 1986 (baseline, 7 days, 1 month)

• Papillary Bleeding Index (PBI) by Saxer and Muhlemann, 1975

• Plaque Index (PI) by Silness and Loe, 1964 (baseline, 7 days, 1 month)

• Pocket Probing Depth (PPD) (baseline, 1 month)

• Clinical Attachment Loss (CAL) (baseline, 1 month)

• Radiographic Evaluation of Bone Level (baseline, 1 month
 
• Modified Gingival Index (MGI) by Lobene et al., 1986 (baseline, 7 days, 1 month)

• Papillary Bleeding Index (PBI) by Saxer and Muhlemann, 1975

• Plaque Index (PI) by Silness and Loe, 1964 (baseline, 7 days, 1 month)

• Pocket Probing Depth (PPD) (baseline, 1 month)

• Clinical Attachment Loss (CAL) (baseline, 1 month)

• Radiographic Evaluation of Bone Level (baseline, 1 month
 
 
Secondary Outcome  
Outcome  TimePoints 
Nil  Nil 
 
Target Sample Size   Total Sample Size="84"
Sample Size from India="84" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   30/04/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Patients having moderate to severe chronic periodontitis will be assigned randomly into 4 groups and will be given mimusops elengi mouthwash, capsules and placebo mouthwash according to the groups. Baseline records will be taken and scaling and root planing will be performed. Upon completion of scaling and root planing patient will be given above mentioned interventions according to their groups. then patient will be assessed at 1 week and 1 month interval and measurement will be recorded for plaque index, modified gingival index, papillary bleeding index, probing pocket depth, clinical attachment loss and then results will be drawn and published 
Close